Product Program year 2025 Source: CMS Open Payments

GORE EXCLUDER Iliac Branch Endoprosthesis

Device Devices

PDI 00733132635283

Open in the dashboard

General payments

$1,134,300

4,040 payments

Research payments

$0

0 payments

Through program year 2025, $1,134,300 in general payments and $0 in research payments were reported against GORE EXCLUDER Iliac Branch Endoprosthesis (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $241,589 865
2024 General $253,337 842
2023 General $403,150 767
2022 General $197,457 1,011
2021 General $38,767 555

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $1,134,300 4,040 payments
Top recipients General payments · program year 2025
  1. Ross Milner Vascular Surgery · Chicago, IL $25,741 11% · 18 payments
  2. Thomas Maldonado Vascular Surgery · New York, NY $18,148 8% · 17 payments
  3. Heron Rodriguez Vascular Surgery · Chicago, IL $13,552 6% · 13 payments
  4. Jason Lee Vascular Surgery · Palo Alto, CA $11,730 5% · 4 payments
  5. Trissa Babrowski Vascular Surgery · Chicago, IL $10,444 4% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $211,939 88% · 342 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $14,742 6% · 22 practitioners
  3. Cardiovascular Disease Internal Medicine $7,143 3% · 6 practitioners
  4. Surgery $2,324 <1% · 38 practitioners
  5. Physician Assistant $897 <1% · 21 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $46,166 19% · 64 recipients
  2. Illinois $39,864 17% · 32 recipients
  3. Indiana $36,193 15% · 3 recipients
  4. New York $34,247 14% · 21 recipients
  5. Texas $20,743 9% · 40 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,040 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record